menu search

Gm and ge agree to develop supply chains to support ev production, renewable energy growth

General Motors Co. GM, +0.67% and General Electric Co. GE, said Wednesday that they signed a memorandum of understanding (MOU) to improve supplies of ...

October 6, 2021, 7:54 am

Gm and ge agree to develop supply chains to support ev production, renewable energy growth

General Motors Co. GM, +0.67% and General Electric Co. GE, said Wednesday that they signed a memorandum of understanding (MOU) to improve supplies of ...

October 6, 2021, 7:54 am

Gm and ge agree to develop supply chains to support ev production, renewable energy growth

General Motors Co. GM, +0.67% and General Electric Co. GE, said Wednesday that they signed a memorandum of understanding (MOU) to improve supplies of ...

October 6, 2021, 7:54 am

Exxonmobil increases participation in scotland carbon capture and storage project

IRVING, Texas--(BUSINESS WIRE)--ExxonMobil has increased its participation in the proposed Acorn carbon capture project in Scotland by signing an Expr...

October 6, 2021, 3:00 am

Exxonmobil increases participation in scotland carbon capture and storage project

IRVING, Texas--(BUSINESS WIRE)--ExxonMobil has increased its participation in the proposed Acorn carbon capture project in Scotland by signing an Expr...

October 6, 2021, 3:00 am

Exxonmobil increases participation in scotland carbon capture and storage project

IRVING, Texas--(BUSINESS WIRE)--ExxonMobil has increased its participation in the proposed Acorn carbon capture project in Scotland by signing an Expr...

October 6, 2021, 3:00 am

Mindmed teams up with sphere health to identify biomarkers associated with anxiety & depression

Psychedelic–focused biotech company Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) disclosed on Tuesday that it has agreed to partner with...

October 5, 2021, 1:15 pm

Mindmed teams up with sphere health to identify biomarkers associated with anxiety & depression

Psychedelic–focused biotech company Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) disclosed on Tuesday that it has agreed to partner with...

October 5, 2021, 1:15 pm

Mindmed teams up with sphere health to identify biomarkers associated with anxiety & depression

Psychedelic–focused biotech company Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) disclosed on Tuesday that it has agreed to partner with...

October 5, 2021, 1:15 pm

Mindmed teams up with sphere health to identify biomarkers associated with anxiety & depression

Psychedelic–focused biotech company Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) disclosed on Tuesday that it has agreed to partner with...

October 5, 2021, 1:15 pm

Mindmed teams up with sphere health to identify biomarkers associated with anxiety & depression

Psychedelic–focused biotech company Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) disclosed on Tuesday that it has agreed to partner with...

October 5, 2021, 1:15 pm

Mindmed teams up with sphere health to identify biomarkers associated with anxiety & depression

Psychedelic–focused biotech company Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) disclosed on Tuesday that it has agreed to partner with...

October 5, 2021, 1:15 pm

Mindmed teams up with sphere health to identify biomarkers associated with anxiety & depression

Psychedelic–focused biotech company Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) disclosed on Tuesday that it has agreed to partner with...

October 5, 2021, 1:15 pm

Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021

Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...

October 5, 2021, 1:00 am

Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021

Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...

October 5, 2021, 1:00 am

Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021

Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...

October 5, 2021, 1:00 am

Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021

Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...

October 5, 2021, 1:00 am

Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021

Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...

October 5, 2021, 1:00 am

Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021

Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...

October 5, 2021, 1:00 am

Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021

Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...

October 5, 2021, 1:00 am


Search within

Pages Search Results: